Towarzystwo Funduszy Inwestycyjnych PZU SA’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $224K | Sell |
1,780
-70
| -4% | -$8.8K | 0.06% | 145 |
|
|
2025
Q1 | $205K | Hold |
1,850
| – | – | 0.07% | 132 |
|
|
2024
Q4 | $253K | Hold |
1,850
| – | – | 0.08% | 103 |
|
|
2024
Q3 | $213K | Buy |
1,850
+110
| +6% | +$12.7K | 0.08% | 110 |
|
|
2024
Q2 | $240K | Hold |
1,740
| – | – | 0.09% | 94 |
|
|
2024
Q1 | $240K | Hold |
1,740
| – | – | 0.1% | 92 |
|
|
2023
Q4 | $229K | Buy |
+1,740
| New | +$229K | 0.11% | 82 |
|
|
2021
Q3 | $141K | Hold |
1,473
| – | – | 0.17% | 70 |
|
|
2021
Q2 | $143K | Hold |
1,473
| – | – | 0.17% | 74 |
|
|
2021
Q1 | $143K | Hold |
1,473
| – | – | 0.21% | 66 |
|
|
2020
Q4 | $141K | Buy |
+1,473
| New | +$141K | 0.15% | 58 |
|